JPWO2020005877A5 - - Google Patents

Download PDF

Info

Publication number
JPWO2020005877A5
JPWO2020005877A5 JP2020572894A JP2020572894A JPWO2020005877A5 JP WO2020005877 A5 JPWO2020005877 A5 JP WO2020005877A5 JP 2020572894 A JP2020572894 A JP 2020572894A JP 2020572894 A JP2020572894 A JP 2020572894A JP WO2020005877 A5 JPWO2020005877 A5 JP WO2020005877A5
Authority
JP
Japan
Prior art keywords
methyl
thiazolo
benzothiazole
fluoro
indazole
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2020572894A
Other languages
English (en)
Japanese (ja)
Other versions
JP7515415B2 (ja
JP2021528466A (ja
Publication date
Application filed filed Critical
Priority claimed from PCT/US2019/038895 external-priority patent/WO2020005877A1/en
Publication of JP2021528466A publication Critical patent/JP2021528466A/ja
Publication of JPWO2020005877A5 publication Critical patent/JPWO2020005877A5/ja
Application granted granted Critical
Publication of JP7515415B2 publication Critical patent/JP7515415B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2020572894A 2018-06-27 2019-06-25 ハンチントン病を処置するためのヘテロアリール化合物 Active JP7515415B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201862690540P 2018-06-27 2018-06-27
US62/690,540 2018-06-27
PCT/US2019/038895 WO2020005877A1 (en) 2018-06-27 2019-06-25 Heteroaryl compounds for treating huntington's disease

Publications (3)

Publication Number Publication Date
JP2021528466A JP2021528466A (ja) 2021-10-21
JPWO2020005877A5 true JPWO2020005877A5 (fi) 2022-06-21
JP7515415B2 JP7515415B2 (ja) 2024-07-12

Family

ID=

Similar Documents

Publication Publication Date Title
JP7399869B2 (ja) ハンチントン病を処置するための化合物
JP2020522570A5 (fi)
AU2019203444B2 (en) Bicyclic lactams and methods of use thereof
JPWO2019191229A5 (fi)
JPWO2020005873A5 (fi)
JPWO2019191092A5 (fi)
KR101812357B1 (ko) Cdk4/6의 억제제로서의 피롤로피리미딘 화합물
HRP20210177T1 (hr) Supstituirani spojevi pirazolo[1,5-a]piridina kao inhibitori ret kinaze
JP2021503004A5 (fi)
JP2015504057A5 (fi)
AU2020277027A1 (en) Compounds for treating huntington's disease
CN112805280A (zh) 用于治疗亨廷顿氏病的杂芳基化合物
JP2014506929A5 (fi)
EP3814360A1 (en) Heteroaryl compounds for treating huntington's disease
HRP20151232T1 (hr) Derivati 2,3-dihidro-1h-inden-1-il-2,7-diazaspiro[3.6]nonana i njihova upotreba kao antagonista ili inverznih agonista grelinskog receptora
JP2011500774A5 (fi)
JP2015537010A5 (fi)
JP2015508075A5 (fi)
JP2011511034A5 (fi)
RU2015122895A (ru) Пуриновые ингибиторы человеческой фосфатидилинозит 3-киназы дельта
HUE032770T2 (en) New NK-3 receptor selective antagonist compounds, pharmaceutical compositions and methods for use in NK-3 receptor mediated disorders
JP2021506941A5 (fi)
CA2649521A1 (en) Novel piperazine compound, and use thereof as hcv polymerase inhibitor
IL297044A (en) Compounds for the treatment of Huntington's disease
JPWO2020231977A5 (fi)